Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2005
05/12/2005US20050100985 Saturation mutagenesis in directed evolution
05/12/2005US20050100984 Expression vector comprising nucleotide sequences coding immunoglobulin fusion directed towards tumors for use in treatment and prevention of cell proliferative disorders; tissue targeted therapy; immunotherapy
05/12/2005US20050100972 Use of grf1 protein for screening molecules
05/12/2005US20050100970 Method of affinity separation and ligands for use therein
05/12/2005US20050100954 Fluorescent proteins from aquatic species
05/12/2005US20050100952 Transgenic mammalian cells for use as bioreactors in expression of heterologous gene sequences
05/12/2005US20050100950 Short anti-sense RNA sequences for use in treatment and prevention of cell proliferative and viral diseases
05/12/2005US20050100936 Methods and compositions related to prediction of drug response
05/12/2005US20050100934 Method for assaying protein-protein interaction
05/12/2005US20050100927 Using transgenic corynebacterium which over expresses dihydropicolinate synthase to ferment lysine for use in cosmetics, medicines and animal feeds
05/12/2005US20050100921 Genomics applications for modified OLIGO nucleotides
05/12/2005US20050100918 Mammalian receptor proteins; related reagents and methods
05/12/2005US20050100917 Mammalian receptor proteins; related reagents and methods
05/12/2005US20050100913 RNA interference pathway genes as tools for targeted genetic interference
05/12/2005US20050100912 Nucleotide sequences coding polymerase delta small subunit (POLD2), adipocyte enhancer binding protein 1 (AEBP1) and membrane fusion protein (SNARE) for use in diagnosis, prevention and treatment of osteopenic disorders
05/12/2005US20050100910 Amplifying a nucleic acid; ligating different oligomers hybridizable to primers of the same melting temperature, simultaneous PCR of the groups of DNA fragments ligated with the oligomers, detecting PCR amplified DNA fragments
05/12/2005US20050100909 Microarray for detecting allelic variants which reduce efficacy of interferon therapies as a treatment of hepatitis c infection
05/12/2005US20050100908 PC4 transcriptional coactivators
05/12/2005US20050100907 Method and medicament for inhibiting the expression of a given gene
05/12/2005US20050100905 Immobilization; solid phase synthesis; quantitative/qualitative analysis; polymorphisms; drug screening; lyophilization; kits
05/12/2005US20050100900 Using solid support comprising immobilized primer and cyclic replication as tools in propagattion of preferential nucleotide sequences; gene expression analysis; identifying restriction fragment length polymorphisms
05/12/2005US20050100898 Compositions and methods for genetic analysis of polycystic kidney disease
05/12/2005US20050100896 Amino acid sequences comprising dombrook antigens for use as diagnostic tool in transfusion medicine; blood typing
05/12/2005US20050100895 Using conditionally replication-competent adenoviruses transcription as diagnostic indicator of cell proliferative disorders of alimentary canal; tissue targeted therapy; drug delivery
05/12/2005US20050100894 Novel mitogen activated kinase
05/12/2005US20050100892 Expression vector comprising nucleotide sequences coding bacterial insecticidal protein for use in transformation and propagation of disease resistant crop plants; biological pest control
05/12/2005US20050100891 Identifying modulators which control endothelial cell and viral gene expression; diagnosis and treatment of cell proliferative disorders; viricides; anticancer agents
05/12/2005US20050100890 Viron for use as gene transfer construct; gene therapy and tissue targeted therapy; drug delivery
05/12/2005US20050100888 Using transcription factor profiles and vectors comprising reporter molecules under regulatory control of transcrption factor as tool in detection of cell proliferative disorders
05/12/2005US20050100886 Nucleotide sequences coding dengu virus non-structural and west nile structural protein for use as tool in generating attenuated west nile viral vaccine
05/12/2005US20050100885 Compositions and methods for the treatment of severe acute respiratory syndrome (SARS)
05/12/2005US20050100884 Using nematode model to identify modulator for prevention and treatment of vesicular stomatitis virus infection
05/12/2005US20050100882 Viral polypeptide fusion comprising guanylyltransferase, methyltransferase and polymerase activities for use as tool in identifying modulator of viral propagation; viricides
05/12/2005US20050100817 Compositions, systems, and methods for imaging
05/12/2005US20050100653 Grain based feed that provide improved animal nutrition, and reduces the environmental impact of animal production
05/12/2005US20050100555 Synovial tissue binding peptide; amino acid sequence motifs; identify binding peptides by grafting tissue of first species into second having attenuated immunological response
05/12/2005US20050100552 Baculovirus vector, expressed in insect cells; induce apoptosis; introduced into tumor cell by viral vector, liposome, a conjugate, injection, electroporation, particle bombardment
05/12/2005US20050100545 Mutated antibody does not possess O-linked glycosylation, nucleic acids encoding prevents N-linked glycosylation; humanized and conjugated with radionucleotide to image target cells
05/12/2005US20050100541 Ligands, including antibodies, showing reactivity against endocrine cells
05/12/2005US20050100540 Platelet-activating factor acetylhydrolase
05/12/2005US20050100527 Liposomes for transfection of nucleic acids
05/12/2005CA2551074A1 Hcv ns3-ns4a protease resistance mutants
05/12/2005CA2544786A1 Method for producing gene transferred dendritic cells
05/12/2005CA2544473A1 A recombinant protein having an anti-cancer effect, its encoding gene and uses thereof
05/12/2005CA2544365A1 Modified anti-cd52 antibody
05/12/2005CA2544300A1 Dose-dependent promoter originating in humans
05/12/2005CA2544272A1 Meg1 endosperm-specific promoters and genes
05/12/2005CA2544125A1 Use of ephrins and related molecules to regulate cellular proliferation
05/12/2005CA2543999A1 Monkey npy y4 receptor and method of evaluating compound
05/12/2005CA2543954A1 Method of designing sirnas for gene silencing
05/12/2005CA2543935A1 Novel phosphate-binding protein, pharmaceutical compositions containing same and use thereof
05/12/2005CA2543763A1 Bacterial virulence factors and uses thereof
05/12/2005CA2543548A1 Expression system for the b subunit of cholera toxin
05/12/2005CA2543522A1 Phosphodiesterase 9 inhibition as treatment for obesity-related conditions
05/12/2005CA2543451A1 High troughput functional assay for g-protein coupled receptors using a rap-ras chimeric protein
05/12/2005CA2543135A1 Methods and compositions for treating 5alpha-reductase type 1 and type 2 dependent conditions
05/12/2005CA2543127A1 Primate prokineticin and prokineticin receptor polypeptides, related compositions and methods
05/12/2005CA2542992A1 Method for identifying compounds that affect expression of tryptophan hydroxylase isoform 2
05/12/2005CA2542904A1 Iap nucleobase oligomers and oligomeric complexes and uses thereof
05/12/2005CA2542884A1 Treatment of proliferative diseases using an antisense iap oligomer and chemotherapeutic agent
05/12/2005CA2542875A1 Method and antisense composition for selective inhibition of hiv infection in hematopoietic cells
05/12/2005CA2542874A1 Compositions of stabilized dna for coating microprojections
05/12/2005CA2542810A1 Methods, compositions and devices for inducing stasis in tissues and organs
05/12/2005CA2542806A1 Methods, compositions and devices for inducing stasis in cells, tissues, organs, and organisms
05/12/2005CA2541852A1 Bone morphogenetic protein (bmp) 2a and uses thereof
05/12/2005CA2540949A1 C-class oligonucleotide analogs with enhanced immunostimulatory potency
05/12/2005CA2539576A1 Method for linking sequences of interest
05/12/2005CA2538695A1 Clq related protein
05/12/2005CA2537236A1 Anti-angiogenic peptides for treating or preventing endometriosis
05/12/2005CA2536238A1 Humanization of antibodies
05/12/2005CA2534236A1 Lipoparticles comprising proteins, methods of making, and using the same
05/11/2005EP1530043A1 Analytic chip for quantifying nucleic acid concentration, analytic device for quantifying nucleic acid concentration and analytic method for quantifying nucleic acid concentration
05/11/2005EP1529845A2 Fusion glycoprotein from HCMV and HSV
05/11/2005EP1529844A2 Complex formation for the stabilisation and purification of proteins of interest
05/11/2005EP1529843A2 Novel secreted proteins and their uses
05/11/2005EP1529842A2 Compositions and methods for the treatment of immune related diseases
05/11/2005EP1529841A1 RNA extraction method, RNA extraction reagent, and method for analyzing biological materials
05/11/2005EP1529840A1 A rapid and low cost method for isolating nucleic acid
05/11/2005EP1529839A1 Mutant phosphoribosylpyrophosphate synthetase and method for producing L-histidine
05/11/2005EP1529766A1 Process for fragmentation of fungal, bacterial or yeast cell DNA and for inactivating residual antibiotics in fermentation biomass
05/11/2005EP1529212A2 Nuclear transfer embryo formation method
05/11/2005EP1529118A1 Avian sex determination method
05/11/2005EP1529114A1 Process for preparing peptides with anti-hypertensive properties
05/11/2005EP1529113A1 Vaccinia virus host range genes to increase the titer of avipoxviruses
05/11/2005EP1529112A2 Nucleic acid sequences encoding proteins associated with abiotic stress response
05/11/2005EP1529111A2 Genetically modified non-human mammal cells, procedure for their production and use in toxicity tests
05/11/2005EP1529110A1 Methods of mixing large numbers of heterologous genes
05/11/2005EP1529109A2 Production of multimeric fusion proteins using a c4bp scaffold
05/11/2005EP1529108A2 Albumin-fused ciliary neurotrophic factor
05/11/2005EP1529107A2 Dna vaccines against hantavirus infections
05/11/2005EP1529106A1 Modified tailed oligonucleotides
05/11/2005EP1529105A1 Methods to reprogram splice site selection in pre-messenger rnas
05/11/2005EP1529064A2 Heteropolymeric compound comprising a scaffold, an adjuvant and an antigen, and its use
05/11/2005EP1529063A1 Antibodies anti-c5 component of the complement system and their use
05/11/2005EP1529062A2 Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signaltransduction
05/11/2005EP1529059A2 Porcine leptin protein, antisense and antibody
05/11/2005EP1529055A2 Isolated nucleic acid molecule encoding a novel centromere-associated motor protein, and uses thereof
05/11/2005EP1529054A2 Therapeutic protein and treatments
05/11/2005EP1528915A2 Liposomal vaccine
05/11/2005EP1497458A4 Hydrophobic zone device
1 ... 2027 2028 2029 2030 2031 2032 2033 2034 2035 2036 2037 2038 2039 2040 2041 2042 2043 2044 2045 2046 2047 ... 4023